+
Site Tour

PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

An analysis was performed on real-world outcomes of U.S. Medicare beneficiaries >60 years old with presumed PFO-associated stroke implanted with the Amplatzer™ PFO Occluder or the Amplatzer™ Talisman™ PFO Occluder.

Download

Related Resources

Patent Foramen Ovale Patient Management

EACTS 2022: SMV repair vs replacement

Clinical trial: Piccolo™

TAVI Summit - Cardiac imaging and morphology

TAVI with Navitor Vision - Livecase

LAAO Summit 2022: The big dilemma 1

LAAO Summit 2023: Future perspectives

EACTS 2021: A valve-for-life

TRENDING TOPICS

Epic Mitral – 10-Year Clinical Outcomes

Ten-Year Follow-Up of Mitral Valve Replacement With the Epic Porcine Valve

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platfrom

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline